Allergen Immunotherapy in an HIV+ Patient with Allergic Fungal Rhinosinusitis
Patients with HIV/AIDS can present with multiple types of fungal rhinosinusitis, fungal balls, granulomatous invasive fungal rhinosinusitis, acute or chronic invasive fungal rhinosinusitis, or allergic fungal rhinosinusitis (AFRS). Given the variable spectrum of immune status and susceptibility to...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Case Reports in Immunology |
Online Access: | http://dx.doi.org/10.1155/2015/875260 |
id |
doaj-9bda5cc9f8614ba9b762e7b357d7619d |
---|---|
record_format |
Article |
spelling |
doaj-9bda5cc9f8614ba9b762e7b357d7619d2020-11-25T00:45:00ZengHindawi LimitedCase Reports in Immunology2090-66092090-66172015-01-01201510.1155/2015/875260875260Allergen Immunotherapy in an HIV+ Patient with Allergic Fungal RhinosinusitisIan A. Myles0Satyen Gada1Bacterial Pathogenesis Unit, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 9000 Rockville Pike, Building 33, Room 2W10A, Bethesda, MD 20892, USAAllergy/Immunology/Immunization Service, Department of Medicine, Walter Reed National Military Medical Center, 8901 Wisconsin Avenue, Bethesda, MD 20889, USAPatients with HIV/AIDS can present with multiple types of fungal rhinosinusitis, fungal balls, granulomatous invasive fungal rhinosinusitis, acute or chronic invasive fungal rhinosinusitis, or allergic fungal rhinosinusitis (AFRS). Given the variable spectrum of immune status and susceptibility to severe infection from opportunistic pathogens it is extremely important that clinicians distinguish aggressive fungal invasive fungal disease from the much milder forms such as AFRS. Here we describe a patient with HIV and AFRS to both remind providers of the importance of ruling out invasive fungal disease and outline the other unique features of fungal sinusitis treatment in the HIV-positive population. Additionally we discuss the evidence for and against use of allergen immunotherapy (AIT) for fungal disease in general, as well as the evidence for AIT in the HIV population.http://dx.doi.org/10.1155/2015/875260 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ian A. Myles Satyen Gada |
spellingShingle |
Ian A. Myles Satyen Gada Allergen Immunotherapy in an HIV+ Patient with Allergic Fungal Rhinosinusitis Case Reports in Immunology |
author_facet |
Ian A. Myles Satyen Gada |
author_sort |
Ian A. Myles |
title |
Allergen Immunotherapy in an HIV+ Patient with Allergic Fungal Rhinosinusitis |
title_short |
Allergen Immunotherapy in an HIV+ Patient with Allergic Fungal Rhinosinusitis |
title_full |
Allergen Immunotherapy in an HIV+ Patient with Allergic Fungal Rhinosinusitis |
title_fullStr |
Allergen Immunotherapy in an HIV+ Patient with Allergic Fungal Rhinosinusitis |
title_full_unstemmed |
Allergen Immunotherapy in an HIV+ Patient with Allergic Fungal Rhinosinusitis |
title_sort |
allergen immunotherapy in an hiv+ patient with allergic fungal rhinosinusitis |
publisher |
Hindawi Limited |
series |
Case Reports in Immunology |
issn |
2090-6609 2090-6617 |
publishDate |
2015-01-01 |
description |
Patients with HIV/AIDS can present with multiple types of fungal rhinosinusitis, fungal balls, granulomatous invasive fungal rhinosinusitis, acute or chronic invasive fungal rhinosinusitis, or allergic fungal rhinosinusitis (AFRS). Given the variable spectrum of immune status and susceptibility to severe infection from opportunistic pathogens it is extremely important that clinicians distinguish aggressive fungal invasive fungal disease from the much milder forms such as AFRS. Here we describe a patient with HIV and AFRS to both remind providers of the importance of ruling out invasive fungal disease and outline the other unique features of fungal sinusitis treatment in the HIV-positive population. Additionally we discuss the evidence for and against use of allergen immunotherapy (AIT) for fungal disease in general, as well as the evidence for AIT in the HIV population. |
url |
http://dx.doi.org/10.1155/2015/875260 |
work_keys_str_mv |
AT ianamyles allergenimmunotherapyinanhivpatientwithallergicfungalrhinosinusitis AT satyengada allergenimmunotherapyinanhivpatientwithallergicfungalrhinosinusitis |
_version_ |
1725271997272817664 |